Penn State Health

The Medical Minute: Mammograms and the COVID-19 vaccine

5-May-2021 1:45 PM EDT, by Penn State Health

Newswise — Some women who have gotten vaccinated for COVID-19 have noticed a startling development ― lumps that in the past might have meant cancer.

As health care providers stress the need to get back on track with regularly scheduled exams, they also want women to know how the COVID-19 vaccine might affect both the timing and possible results of their tests.

Swollen lymph nodes, caught on film

COVID-19 vaccines may cause temporary swelling of the lymph nodes in the armpit — called the axilla — in the same arm that was injected. This is normal and expected, said Shelley Tuzzato, chief technologist for outpatient imaging at Penn State Health Lime Spring Outpatient Center.

“Swollen lymph nodes mean that your body is mounting a response to a possible infection,” Tuzzato said. “It could be a simple as a hang nail or a cut on your skin. Or it could be a response to a vaccination.”

Make no mistake, all lumps should still be taken seriously. If a woman discovers one on her own, whether on her breast or in her armpit area, she should contact her doctor for evaluation. But some cases of axillary adenopathy — a change in the size and consistency of lymph nodes in the axilla — only become evident with a mammogram.

Although very rare, occurring in just .02 to .04% of screening mammograms before the COVID-19 vaccine became available, “when a mammogram did show axillary adenopathy, our radar would go up,” said Dr. Julie Mack, a physician with Penn State Health Breast Center. “The reported malignancy rate for a clearly abnormal lymph node is variable — anywhere from 20% to 50% — so we take it seriously.” The cancer could be in the breast or another part of the body or within the immune system itself.

Prescreening and a conservative approach

“Prior to the vaccine, if we found an abnormal lymph node that we couldn’t explain, we would often biopsy it,” Mack said. “Now we correlate the finding to see if it is in the same arm where the shot was recently given. If it fits the typical pattern of benign adenopathy seen after a Covid vaccine, we’ll follow the guidance from the Society of Breast Imaging and follow it with a repeat imaging study to make sure it decreases in size.”

They’ll check again in six to 12 weeks to make sure the swelling has gone down.

“Cancer doesn’t get better on its own,” Mack said.

To help lessen the chances a mammogram might pick up a temporary side effect of the COVID-19 vaccine, schedulers prescreen women for a recent vaccination.

“Our schedulers will ask if they’ve gotten the Pfizer or Moderna vaccine, and if so, when,” Tuzzato said. “If the patient is not significantly overdue for an annual screening, they’ll explain that it’s recommended that they wait for four to six weeks after their second dose.”

Patients who have a specific concern — such as a lump or unusual changes to their breast — should call their doctor and schedule a diagnostic mammogram right away, regardless of when they might have received the COVID-19 vaccine, Tuzzato said.

Protect your health

Screening is voluntary, something done on an annual basis for patients who have no symptoms. It can be delayed for a bit, but not for months on end, Mack said.

“A screening mammogram is the one proven way to lower the mortality rate from breast cancer” Mack said. “And the vaccines are the best protection against developing serious illness, hospitalization and death from COVID-19.  So if you are soon due for your screening exam, get vaccinated, and then in four to six weeks come in for your mammogram.”

Related content:

The Medical Minute is a weekly health news feature produced by Penn State Health. Articles feature the expertise of faculty, physicians and staff, and are designed to offer timely, relevant health information of interest to a broad audience.

Filters close

Showing results

110 of 5862
Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.

Newswise: NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
Released: 23-Jun-2021 11:35 AM EDT
NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
National Institute of Biomedical Imaging and Bioengineering

In a new study, NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.

Released: 23-Jun-2021 11:25 AM EDT
Half of young adults with covid-19 have persistent symptoms 6 months after
University of Bergen

A paper published in the prestigious journal Nature Medicine on long-COVID, describes persistent symptoms six months after acute COVID-19, even in young home isolated people.

Newswise:Video Embedded covid-19-vaccine-hesitancy-dr-vin-gupta-narrates-new-american-thoracic-society-video
Released: 23-Jun-2021 9:40 AM EDT
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
American Thoracic Society (ATS)

The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.

18-Jun-2021 11:00 AM EDT
Had COVID-19? One Vaccine Dose Enough; Boosters For All, Study Says
American Chemical Society (ACS)

A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.

Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Showing results

110 of 5862